68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model

Saved in:
Bibliographic Details
Main Authors: Yu Zhang, Qingqing Li, Fengling Shan, Ao Li, Danni Li, Xiaoxu Dong, Zhiyi Lin, Xiao Li, Shuai Xue, Wenxin Chen
Format: Article
Language:English
Published: American Chemical Society 2025-06-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.5c03248
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850117152457097216
author Yu Zhang
Qingqing Li
Fengling Shan
Ao Li
Danni Li
Xiaoxu Dong
Zhiyi Lin
Xiao Li
Shuai Xue
Wenxin Chen
author_facet Yu Zhang
Qingqing Li
Fengling Shan
Ao Li
Danni Li
Xiaoxu Dong
Zhiyi Lin
Xiao Li
Shuai Xue
Wenxin Chen
author_sort Yu Zhang
collection DOAJ
format Article
id doaj-art-2bb6ea64cc42479a9d7045b5e52e08f8
institution OA Journals
issn 2470-1343
language English
publishDate 2025-06-01
publisher American Chemical Society
record_format Article
series ACS Omega
spelling doaj-art-2bb6ea64cc42479a9d7045b5e52e08f82025-08-20T02:36:09ZengAmerican Chemical SocietyACS Omega2470-13432025-06-011026282862829510.1021/acsomega.5c0324868Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts ModelYu Zhang0Qingqing Li1Fengling Shan2Ao Li3Danni Li4Xiaoxu Dong5Zhiyi Lin6Xiao Li7Shuai Xue8Wenxin Chen9Department of Nuclear Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, ChinaDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, ChinaShanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, ChinaDepartment of Nuclear Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, ChinaDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaDepartment of Nuclear Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Chinahttps://doi.org/10.1021/acsomega.5c03248
spellingShingle Yu Zhang
Qingqing Li
Fengling Shan
Ao Li
Danni Li
Xiaoxu Dong
Zhiyi Lin
Xiao Li
Shuai Xue
Wenxin Chen
68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
ACS Omega
title 68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
title_full 68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
title_fullStr 68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
title_full_unstemmed 68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
title_short 68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
title_sort 68ga 161tb cp2 as a paired radiopharmaceutical targeting kdm4a and the preliminary verification in nci h2228 xenografts model
url https://doi.org/10.1021/acsomega.5c03248
work_keys_str_mv AT yuzhang 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT qingqingli 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT fenglingshan 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT aoli 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT dannili 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT xiaoxudong 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT zhiyilin 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT xiaoli 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT shuaixue 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel
AT wenxinchen 68ga161tbcp2asapairedradiopharmaceuticaltargetingkdm4aandthepreliminaryverificationinncih2228xenograftsmodel